This finding is consistent with previous reports on cervical cancer (24), which found that the expression of NR2F6 was significantly correlated with the clinical stage, survival status, tumor recurrence, chemotherapy, and lymph node metastasis of cervical cancer. The gene discussed is NR2F6; the disease is cervical cancer.